Sintilimab in combination with cetuximab and chemotherapy as first-line treatment for RAS/BRAF wild-type advanced colorectal cancer (CALLIOPSIS): An open-label, non-comparative, phase 1b/2 dose escalation and expansion trial.

Authors: Ying Wang, Shanshan Zheng, Yibo Gao, Yanrong Zhu, Peng Sun, Shou Luo, Zhenzhen Luo, Zesong Chen, Jugao Chen, Xuhao Cai, Yanjiong He, Mingrui Ma, Yonggang Yu, Shi Jin, Dongmei Lan, Yinggang Chen

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.e15531

Source: Full article

---

Abstract

e15531